Literature DB >> 23314555

Elevated tumor markers in patients with pulmonary alveolar proteinosis.

Shen-Cun Fang1, Kai-Hua Lu, Cai-Ying Wang, Hai-Tao Zhang, Ying-Ming Zhang.   

Abstract

BACKGROUND: The role of tumor markers in pulmonary alveolar proteinosis (PAP) remains unclear. This study investigated the tumor markers in serum and bronchoalveolar lavage fluid (BALF) in PAP patients and explored the relationship between tumor markers and the severity of PAP.
METHODS: We retrospectively reviewed 38 patients with PAP.
RESULTS: Mean serum carcinoembryonic antigen (CEA) and CYFRA21-1 levels were higher than the cut-off values (12.7 ± 17.5 ng/mL and 10 ± 10.66 ng/mL, respectively). Significant correlations were found between levels of CEA and neuron-specific enolase (NSE) in serum and serum lactate dehydrogenase (LDH) values (r=0.60, p<0.001 and r=0.56, p<0.001, respectively). A significant correlation was also observed between levels of squamous cell carcinoma (SCC) in serum and PaO2 and PA-aO2 (r=-0.49 p=0.01 and r=-0.51, p=0.01, respectively). The changes of CEA, SCC and NSE levels were consistent with the changes of LDH and PaO2. The serum levels of CEA, NSE and SCC were significantly lower after whole lung lavage compared with those before (8.7 ± 10.6 vs. 15.7 ± 22, 7.9 ± 5.2 vs. 16.6 ± 11.8, 0.4 ± 0.24 vs. 0.59 ± 0.42; p<0.05, respectively).
CONCLUSIONS: Elevated serum tumor marker levels were found in PAP patients. The serum levels of CEA, NSE and SCC may reflect the severity of the disease and predict the therapeutic effect of whole lung lavage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23314555     DOI: 10.1515/cclm-2012-0738

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  Role of Neuron-Specific Enolase in the Diagnosis and Disease Monitoring of Sarcoidosis.

Authors:  Noriaki Sunaga; Yasuhiko Koga; Yoshimasa Hachisu; Koichi Yamaguchi; Masaki Aikawa; Norimitsu Kasahara; Yosuke Miura; Hiroaki Tsurumaki; Masakiyo Yatomi; Reiko Sakurai; Toshitaka Maeno; Takeshi Hisada
Journal:  Can Respir J       Date:  2022-05-26       Impact factor: 2.130

2.  Clinical significance of cigarette smoking and dust exposure in pulmonary alveolar proteinosis: a Korean national survey.

Authors:  Ji An Hwang; Joo Han Song; Jung Hoon Kim; Man Pyo Chung; Dong Soon Kim; Jin Woo Song; Young Whan Kim; Sun Mi Choi; Seung Ick Cha; Soo Taek Uh; Choon-Sik Park; Sung Hwan Jeong; Yong Bum Park; Hong Lyeol Lee; Jong Wook Shin; Eun Joo Lee; Yangjin Jegal; Hyun Kyung Lee; Jong Sun Park; Moo Suk Park
Journal:  BMC Pulm Med       Date:  2017-11-21       Impact factor: 3.317

3.  Multifunctional neuron-specific enolase: its role in lung diseases.

Authors:  Cai-Ming Xu; Ya-Lan Luo; Shuai Li; Zhao-Xia Li; Liu Jiang; Gui-Xin Zhang; Lawrence Owusu; Hai-Long Chen
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

4.  CYFRA21-1 is a more sensitive biomarker to assess the severity of pulmonary alveolar proteinosis.

Authors:  Jiu-Wu Bai; Shui-Yi Gu; Xiao-Li Sun; Hai-Wen Lu; Shuo Liang; Jin-Fu Xu
Journal:  BMC Pulm Med       Date:  2022-01-03       Impact factor: 3.317

Review 5.  The Clinical Clues of Pulmonary Alveolar Proteinosis: A Report of 11 Cases and Literature Review.

Authors:  Qiongya Mo; Bingbin Wang; Nian Dong; Lianmin Bao; Xiaoqiong Su; Yuping Li; Chengshui Chen
Journal:  Can Respir J       Date:  2016-04-26       Impact factor: 2.409

6.  Valuable Serum Markers in Pulmonary Alveolar Proteinosis.

Authors:  Shenyun Shi; Lulu Chen; Xiaohua Qiu; Qi Zhao; Yonglong Xiao; Xin Yan
Journal:  Dis Markers       Date:  2019-11-11       Impact factor: 3.434

7.  Association of pulmonary sequestration with elevated serum cancer antigen 125 levels: a case report.

Authors:  Guojie Teng; Xiuhong Nie; Dandan Wang
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.